牛牛AI助手已提取核心信息华润医药集团2025年上半年实现总收益人民币1,318.67亿元，同比增长2.5%。期内净利润50.54亿元，同比下降8.8%；本公司拥有人应占溢利20.77亿元，同比下降20.3%。剔除联营公司减值等一次性项目影响，净利润同比略降1.3%。董事会宣派中期股息每股人民币0.072元。制药业务实现分部收益248.08亿元，同比增长4.3%，毛利率为59.3%。中药业务收益...
Source Link牛牛AI助手已提取核心信息华润医药集团2025年上半年实现总收益人民币1,318.67亿元，同比增长2.5%。期内净利润50.54亿元，同比下降8.8%；本公司拥有人应占溢利20.77亿元，同比下降20.3%。剔除联营公司减值等一次性项目影响，净利润同比略降1.3%。董事会宣派中期股息每股人民币0.072元。制药业务实现分部收益248.08亿元，同比增长4.3%，毛利率为59.3%。中药业务收益...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.